image credit- shutterstock
Teddy Laboratory, a subsidiary of Tigermed, has officially signed a strategic cooperation agreement with LabConnect, LLC, a global leader in central laboratory services.
The two parties will jointly build a full-chain laboratory service system covering both China and international markets to accelerate the development and commercialization of innovative drugs worldwide.
With this agreement, Teddy Laboratory will become LabConnect's preferred laboratory partner in China, providing lab services that meet international regulatory standards and supporting multinational pharmaceutical companies conducting clinical trials in China.
Meanwhile, LabConnect will become Teddy Lab's preferred central lab partner for overseas operations, leveraging its extensive presence in key markets such as North America and Europe to help Chinese pharmaceutical companies expand globally.
Teddy Laboratory and LabConnect will establish a long-term preferred partnership, forming a complementary model of "China-based capabilities + global service network." "By fully leveraging our respective resources and technological strengths, we aim to further enhance global clinical trial service standards," said Jeff Mayhew Chief Development Officer of LabConnect.
This strategic partnership marks not only a key milestone in Teddy Laboratories global expansion but also a deep integration of domestic and international central lab resources. In the future, both parties will continue working together to enhance global clinical trial service capabilities, support the development and launch of innovative drugs worldwide, and bring more advanced treatment options to patients.
